Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MicroPort NeuroTech Limited ( (HK:2172) ) has provided an update.
MicroPort NeuroScientific Corporation has called its annual general meeting for 3 June 2026 in Shanghai, where shareholders will review the audited financial statements for the year ended 31 December 2025 and vote on board and auditor matters. The agenda includes approving a final dividend of HK$0.09 per share via a scrip dividend scheme, re-electing five directors with authority for the board to set their remuneration, re-appointing KPMG and KPMG Huazhen LLP as auditors, and granting a general mandate for the company to buy back up to 10% of its issued shares, which could affect capital structure and shareholder returns.
More about MicroPort NeuroTech Limited
MicroPort NeuroScientific Corporation, incorporated in the Cayman Islands and listed in Hong Kong, operates in the neurotechnology and medical devices sector. The company focuses on developing and commercializing neuro-interventional and related products, serving hospitals and healthcare providers, with its core market activities and corporate functions centered in mainland China.
Average Trading Volume: 2,362,557
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.07B
For a thorough assessment of 2172 stock, go to TipRanks’ Stock Analysis page.